Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 268

1.

Ureterolithotripsy for a Ureteral Calculus at the Ureteroureterostomy of a Renal-transplant Recipient.

Mitsui Y, Wada K, Araki M, Yoshioka T, Ariyoshi Y, Nishimura S, Kobayashi Y, Sasaki K, Watanabe T, Nasu Y.

Acta Med Okayama. 2017 Oct;71(5):449-452. doi: 10.18926/AMO/55445.

2.

Overexpression of REIC/Dkk-3 suppresses the expression of CD147 and inhibits the proliferation of human bladder cancer cells.

Horikawa Y, Watanabe M, Sadahira T, Ariyoshi Y, Kobayashi Y, Araki M, Wada K, Ochiai K, Li SA, Nasu Y.

Oncol Lett. 2017 Sep;14(3):3223-3228. doi: 10.3892/ol.2017.6548. Epub 2017 Jul 8.

3.

Robotic Renal Autotransplantation: First Case Outside of North America.

Araki M, Wada K, Mitsui Y, Sadahira T, Kubota R, Nishimura S, Yoshioka T, Ariyoshi Y, Fujio K, Takamoto A, Sugimoto M, Sasaki K, Kobayashi Y, Ebara S, Taninishi H, Amano H, Inui M, Watanabe M, Watanabe T, Nasu Y.

Acta Med Okayama. 2017 Aug;71(4):351-355. doi: 10.18926/AMO/55313.

4.

The assessment of renal cortex and parenchymal volume using automated CT volumetry for predicting renal function after donor nephrectomy.

Mitsui Y, Sadahira T, Araki M, Wada K, Tanimoto R, Ariyoshi Y, Kobayashi Y, Watanabe M, Watanabe T, Nasu Y.

Clin Exp Nephrol. 2017 Jul 24. doi: 10.1007/s10157-017-1454-1. [Epub ahead of print]

PMID:
28741049
5.

The Downregulation of the Expression of CD147 by Tumor Suppressor REIC/Dkk-3, and Its Implication in Human Prostate Cancer Cell Growth Inhibition.

Mori A, Watanabe M, Sadahira T, Kobayashi Y, Ariyoshi Y, Ueki H, Wada K, Ochiai K, Li SA, Nasu Y.

Acta Med Okayama. 2017 Apr;71(2):135-142. doi: 10.18926/AMO/54982.

6.

Evaluation of Urinary Stone Composition and Differentiation between Urinary Stones and Phleboliths Using Single-source Dual-energy Computed Tomography.

Ogawa N, Sato S, Ida K, Kato K, Ariyoshi Y, Wada K, Nasu Y, Kanazawa S.

Acta Med Okayama. 2017 Apr;71(2):91-96. doi: 10.18926/AMO/54976.

7.

Clinical pharmacokinetics of oral levofloxacin and sitafloxacin in epididymal tissue.

Sadahira T, Wada K, Ikawa K, Morikawa N, Kurahashi H, Yoshioka T, Ariyoshi Y, Kobayashi Y, Araki M, Ishii A, Watanabe M, Uehara S, Watanabe T, Nasu Y.

J Infect Chemother. 2017 Apr;23(4):214-217. doi: 10.1016/j.jiac.2016.12.010. Epub 2017 Jan 11.

PMID:
28089362
8.

Successful microscopic renal autotransplantation for left renal aneurysm associated with segmental arterial mediolysis.

Yoshioka T, Araki M, Ariyoshi Y, Wada K, Tanaka N, Nasu Y.

J Vasc Surg. 2017 Jul;66(1):261-264. doi: 10.1016/j.jvs.2016.09.039. Epub 2016 Dec 14.

PMID:
27988157
9.

Na+/H+ exchanger 1 has tumor suppressive activity and prognostic value in esophageal squamous cell carcinoma.

Ariyoshi Y, Shiozaki A, Ichikawa D, Shimizu H, Kosuga T, Konishi H, Komatsu S, Fujiwara H, Okamoto K, Kishimoto M, Marunaka Y, Otsuji E.

Oncotarget. 2017 Jan 10;8(2):2209-2223. doi: 10.18632/oncotarget.13645.

10.

Adenovirus vector carrying REIC/DKK-3 gene: neoadjuvant intraprostatic injection for high-risk localized prostate cancer undergoing radical prostatectomy.

Kumon H, Ariyoshi Y, Sasaki K, Sadahira T, Araki M, Ebara S, Yanai H, Watanabe M, Nasu Y.

Cancer Gene Ther. 2016 Nov;23(11):400-409. doi: 10.1038/cgt.2016.53. Epub 2016 Oct 21.

11.

Efficacy and safety of 3 day versus 7 day cefditoren pivoxil regimens for acute uncomplicated cystitis: multicentre, randomized, open-label trial.

Sadahira T, Wada K, Araki M, Ishii A, Takamoto A, Kobayashi Y, Watanabe M, Watanabe T, Nasu Y, Kumon H; Okayama Urological Research Group (OURG).

J Antimicrob Chemother. 2017 Feb;72(2):529-534. doi: 10.1093/jac/dkw424. Epub 2016 Oct 12.

PMID:
27733519
12.

The Efficacy of Rituximab in High-risk Renal Transplant Recipients.

Araki M, Wada K, Mitsui Y, Kubota R, Yoshioka T, Ariyoshi Y, Kobayashi Y, Kitagawa M, Tanabe K, Sugiyama H, Wada J, Watanabe M, Watanabe T, Hotta K, Nasu Y.

Acta Med Okayama. 2016 Aug;70(4):295-7.

13.

The induction of antigen-specific CTL by in situ Ad-REIC gene therapy.

Ariyoshi Y, Watanabe M, Eikawa S, Yamazaki C, Sadahira T, Hirata T, Araki M, Ebara S, Nasu Y, Udono H, Kumon H.

Gene Ther. 2016 May;23(5):408-14. doi: 10.1038/gt.2016.7. Epub 2016 Feb 2.

PMID:
26836118
14.

Tumor suppressor REIC/DKK-3 and co-chaperone SGTA: Their interaction and roles in the androgen sensitivity.

Ochiai K, Morimatsu M, Kato Y, Ishiguro-Oonuma T, Udagawa C, Rungsuriyawiboon O, Azakami D, Michishita M, Ariyoshi Y, Ueki H, Nasu Y, Kumon H, Watanabe M, Omi T.

Oncotarget. 2016 Jan 19;7(3):3283-96. doi: 10.18632/oncotarget.6488.

15.

Feasibility of Neoadjuvant Ad-REIC Gene Therapy in Patients with High-Risk Localized Prostate Cancer Undergoing Radical Prostatectomy.

Kumon H, Sasaki K, Ariyoshi Y, Sadahira T, Araki M, Ebara S, Yanai H, Watanabe M, Nasu Y.

Clin Transl Sci. 2015 Dec;8(6):837-40. doi: 10.1111/cts.12362. Epub 2015 Dec 1.

16.

Ad-REIC Gene Therapy: Promising Results in a Patient with Metastatic CRPC Following Chemotherapy.

Kumon H, Sasaki K, Ariyoshi Y, Sadahira T, Ebara S, Hiraki T, Kanazawa S, Yanai H, Watanabe M, Nasu Y.

Clin Med Insights Oncol. 2015 Mar 23;9:31-8. doi: 10.4137/CMO.S23252. eCollection 2015.

17.

[A case of mediastinal recurrence of esophageal cancer diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration].

Ariyoshi Y, Shiozaki A, Fujiwara H, Konishi H, Morimura R, Murayama Y, Komatsu S, Kuriu Y, Ikoma H, Kubota T, Nakanishi M, Ichikawa D, Okamoto K, Sakakura C, Iwasaki Y, Otsuji E.

Gan To Kagaku Ryoho. 2014 Nov;41(12):2372-4. Japanese.

PMID:
25731527
18.

A novel gene expression system strongly enhances the anticancer effects of a REIC/Dkk-3-encoding adenoviral vector.

Watanabe M, Sakaguchi M, Kinoshita R, Kaku H, Ariyoshi Y, Ueki H, Tanimoto R, Ebara S, Ochiai K, Futami J, Li SA, Huang P, Nasu Y, Huh NH, Kumon H.

Oncol Rep. 2014 Mar;31(3):1089-95. doi: 10.3892/or.2013.2958. Epub 2013 Dec 31.

19.

[Minimally invasive surgery for cancer arising in a reconstructed gastric tube after esophagectomy based on evaluation of blood and lymphatic flow by indocyanine green fluorescence imaging].

Ariyoshi Y, Fujiwara H, Shiozaki A, Konishi H, Komatsu S, Kubota T, Ichikawa D, Okamoto K, Morimura R, Murayama Y, Kuriu Y, Ikoma H, Nakanishi M, Kimura A, Sakakura C, Otsuji E.

Gan To Kagaku Ryoho. 2013 Nov;40(12):2170-2. Japanese.

PMID:
24394049
20.

Efficacy and safety of rotigotine in Japanese patients with restless legs syndrome: a phase 3, multicenter, randomized, placebo-controlled, double-blind, parallel-group study.

Inoue Y, Shimizu T, Hirata K, Uchimura N, Ishigooka J, Oka Y, Ikeda J, Tomida T, Hattori N; Rotigotine Trial Group.

Sleep Med. 2013 Nov;14(11):1085-91. doi: 10.1016/j.sleep.2013.07.007. Epub 2013 Aug 21.

PMID:
24055212

Supplemental Content

Loading ...
Support Center